Clarivate PLC (CCC): Price and Financial Metrics
GET POWR RATINGS... FREE!
CCC Stock Price Chart Interactive Chart >
CCC Price/Volume Stats
|Current price||$28.94||52-week high||$33.55|
|Prev. close||$29.17||52-week low||$15.00|
|Day high||$29.58||Avg. volume||1,238,000|
|50-day MA||$29.13||Dividend yield||N/A|
|200-day MA||$27.02||Market Cap||17.54B|
Clarivate PLC (CCC) Company Bio
Clarivate Plc provides trusted insights and analytics to accelerate the pace of innovation. Its solutions include scientific and research, patent intelligence and compliance standards, pharmaceutical and biotech intelligence and trademark, domain and brand protection. The company product portfolio includes Life Science, Web of Science, Cortellis, Derwent, CompuMark, MarkMonitor and Techstreet. It helps clients to reduce the time from new ideas to life changing innovations. The company was founded in 1864 and is headquartered in London.
Most Popular Stories View All
CCC Latest News Stream
|Loading, please wait...|
CCC Latest Social Stream
View Full CCC Social Stream
Latest CCC News From Around the Web
Below are the latest news stories about CLARIVATE Plc that investors may wish to consider to help them evaluate CCC as an investment opportunity.
Researchers can stay informed of latest scientific research developments as part of 'new Web of Science'LONDON, Jan. 25, 2021 /CNW/ -- Clarivate Plc (NYSE:CCC), a global leader in providing trusted information and insights to accelerate the pace of innovation, today launched Web of Science™ My Research Assistant, a mobile-only application that enables scientific researchers to easily search, save and share publication records of the trusted research data in the Web of Science citation index using their mobile devices.
Clarivate Plc (NYSE: CCC), a global leader in providing trusted information and insights to accelerate the pace of innovation, announced today that its ticker symbol on the New York Stock Exchange will change to "CLVT" from "CCC." Trading under the new ticker symbol will begin on Monday, February 1, 2021.
Clarivate Enhances Cortellis CMC Intelligence Platform with Addition of Comprehensive Biologics Content
Complete insights on biologic CMC requirements enable pharma, biotech and generics organizations to accelerate innovation by bringing life-saving medicines to patients fasterLONDON, Jan. 20, 2021 /CNW/ -- Clarivate Plc (NYSE: CCC), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced the enhancement of Cortellis CMC Intelligence™, the world's only organized, timely and accurate source of Chemistry, Manufacturing and Controls (CMC) regulations and local practices.
Clarivate Plc (NYSE: CCC), a global leader in providing trusted information and insights to accelerate the pace of innovation, announced today that Karen G. Mills, a member of the board of directors, has informed the Company of her decision to step down from the board to spend time on other endeavors. With Ms. Mills' departure, the Clarivate Board will consist of 11 members.
IPO Edge was pleased to host Michael Klein, Chairman and CEO of Churchill Capital Corp, for a fireside chat during the 23rd Annual ICR Virtual Conference on January 12. Mr. Klein spoke with IPO Edge Editor-in-Chief John Jannarone for over an hour, discussing topics including: The most attractive industry sectors for SPACs The emergence of pre-revenue companies […]
CCC Price Returns